Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Oliver Overheu"'
Autor:
Thilo Gambichler, Jonas Rüth, Silke Goesmann, Stefan Höxtermann, Marina Skrygan, Laura Susok, Jürgen C. Becker, Oliver Overheu, Wolfgang Schmidt, Anke Reinacher-Schick
Publikováno v:
Viruses, Vol 16, Iss 5, p 810 (2024)
In patients with COVID-19, broad panels of immune checkpoint molecules (ICPMs) and the purinergic signaling have not been studied in parallel. We aimed to perform in-depth immunophenotyping of major cell subsets present in human peripheral blood of C
Externí odkaz:
https://doaj.org/article/878c6a3945914e50a4b3dfc8f93469e1
Autor:
Thilo Gambichler, Nadine Schuleit, Laura Susok, Jürgen C. Becker, Christina H. Scheel, Christian Torres-Reyes, Oliver Overheu, Anke Reinacher-Schick, Wolfgang Schmidt
Publikováno v:
Viruses, Vol 15, Iss 9, p 1920 (2023)
With the end of the pandemic, COVID-19 has entered an endemic phase with expected seasonal spikes. Consequently, the implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of research. In this m
Externí odkaz:
https://doaj.org/article/019e0dd69a4c40ccb710325b66138446
Autor:
Clara Bessen, Carlos Plaza-Sirvent, Agit Simsek, Jaydeep Bhat, Corinna Marheinecke, Doris Urlaub, Petra Bonowitz, Sandra Busse, Sabrina Schumann, Elena Vidal Blanco, Adriane Skaletz-Rorowski, Norbert H. Brockmeyer, Oliver Overheu, Anke Reinacher-Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Anja Potthoff, Ingo Schmitz
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite the development of vaccines, which protect healthy people from severe and life-threatening Covid-19, the immunological responses of people with secondary immunodeficiencies to these vaccines remain incompletely understood. Here, we investigat
Externí odkaz:
https://doaj.org/article/abc6f45fd07d4397b50f0ec012acf870
Autor:
Simon Faissner, Neele Heitmann, Carlos Plaza-Sirvent, Paulina Trendelenburg, Ulas Ceylan, Jeremias Motte, Clara Bessen, Doris Urlaub, Carsten Watzl, Oliver Overheu, Anke Reinacher-Schick, Kerstin Hellwig, Stephanie Pfaender, Ingo Schmitz, Ralf Gold
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveThe pandemic induced by SARS-CoV-2 has huge implications for patients with immunosuppression that is caused by disorders or specific treatments. Especially approaches targeting B cells via anti-CD20 therapy are associated with impaired humor
Externí odkaz:
https://doaj.org/article/16755a7f2810435ca56819e9ce9af063
Autor:
Oliver Overheu, Simon Lendowski, Daniel R. Quast, Corinna S. Marheinecke, Eleni Kourti, Celine Lugnier, Ioana Andreica, Uta Kiltz, Stephanie Pfaender, Anke Reinacher-Schick
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:1985-1992
Purpose Refusal to receive SARS-CoV-2 vaccination poses a threat to fighting the COVID-19 pandemic. Little is known about German cancer patients’ attitude towards and experience with SARS-CoV-2 vaccination. Methods Patients were enrolled between 04
Autor:
Doreen Maria Gisder, Oliver Overheu, Julia Keller, Stefanie Nöpel-Dünnebacke, Waldemar Uhl, Anke Reinacher-Schick, Andrea Tannapfel, Iris Tischoff
Publikováno v:
Pathobiology. 90:71-80
Introduction: Studies on pancreatic neuroendocrine tumors (PanNETs) regarding loss of ATRX, DAXX, or frequency of microsatellite instability (MSI) show inconclusive results. So far, data on corresponding metastaseshave not been published. Methods: We
Autor:
Agit Simsek, Clara Bessen, Toni L Meister, Doris Urlaub, Adriane Skaletz‐Rorowski, Norbert H Brockmeyer, Oliver Overheu, Anke Reinacher‐Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Ingo Schmitz, Anja Potthoff, Carlos Plaza‐Sirvent
Publikováno v:
Journal of the European Academy of Dermatology and Venereology.
Autor:
Türkan Sakinc-Güler, Anke Reinacher-Schick, Wolfgang Schmidt, Oliver Overheu, Daniel R. Quast
Publikováno v:
Oncology Research and Treatment
Background: Coronavirus disease 2019 (COVID-19) cases in Germany, as in most other places in Europe or worldwide, are still highly prevalent. Vaccination rates currently remain low, putting cancer patients at a continued risk of infection with SARS-C
Autor:
Celine Lugnier, Sarah Foerster, Anna-Lena Kraeft, Inke Sabine Feder, Jens Christmann, Eleni Kourti, Oliver Overheu, Sabine Sommerlatte, Waldemar Uhl, Martin Schoenlein, Vivian Rosery, Christoph Biermann, Lothar Müller, Olaf Schoffer, Jochen Schmitt, Dominik Paul Modest, Volker Heinemann, Jan Schildmann, Anke C. Reinacher-Schick, Andrea Tannapfel
3626 Background: CRC still is one of the leading causes of cancer related death though prognosis has improved through guideline based management. The COVID-19 pandemic lead to re-allocation of resources subordinating all sections of care for CRC pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b471feb9a628c3771172ea1671b099
Autor:
Doreen Maria, Gisder, Oliver, Overheu, Julia, Keller, Stefanie, Nöpel-Dünnebacke, Waldemar, Uhl, Anke, Reinacher-Schick, Andrea, Tannapfel, Iris, Tischoff
Publikováno v:
Pathobiology : journal of immunopathology, molecular and cellular biology.
Studies on pancreatic neuroendocrine tumors (PanNETs) regarding loss of ATRX, DAXX, or frequency of microsatellite instability (MSI) show inconclusive results. So far, data on corresponding metastaseshave not been published.We performed immunohistoch